Cue Biopharma (CUE) Revenue Growth (1y) (2019 - 2025)
Cue Biopharma (CUE) Revenue Growth (1y) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Revenue Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
37.90% |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
64.24% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
7.82% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Cue Biopharma |
581.16 Mn |
553.47 Mn |
- |
502.79% |
| Date | Value |
|---|
| Dec 31, 2025 |
502.79% |
| Sep 30, 2025 |
-35.58% |
| Jun 30, 2025 |
11.14% |
| Mar 31, 2025 |
-75.48% |
| Dec 31, 2024 |
-13.45% |
| Sep 30, 2024 |
58.86% |
| Jun 30, 2024 |
92.33% |
| Mar 31, 2024 |
818.18% |
| Dec 31, 2023 |
1,105.96% |
| Sep 30, 2023 |
2,988.24% |
| Jun 30, 2023 |
5,215.38% |
| Mar 31, 2023 |
-81.30% |
| Dec 31, 2022 |
-98.17% |
| Sep 30, 2022 |
-97.16% |
| Jun 30, 2022 |
-99.05% |
| Mar 31, 2022 |
-35.61% |
| Dec 31, 2021 |
1,636.57% |
| Sep 30, 2021 |
240.20% |
| Jun 30, 2021 |
154.79% |
| Mar 31, 2021 |
72.56% |
